BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11406554)

  • 1. A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.
    Akalin A; Elmore LW; Forsythe HL; Amaker BA; McCollum ED; Nelson PS; Ware JL; Holt SE
    Cancer Res; 2001 Jun; 61(12):4791-6. PubMed ID: 11406554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas.
    Elmore LW; Forsythe R; Forsythe H; Bright AT; Nasim S; Endo K; Holt SE
    Oncol Rep; 2008 Sep; 20(3):613-7. PubMed ID: 18695913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of telomerase activity by six telomerase subunits.
    Chang JT; Chen YL; Yang HT; Chen CY; Cheng AJ
    Eur J Biochem; 2002 Jul; 269(14):3442-50. PubMed ID: 12135483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of HSP90 and p23 in the telomerase complex of thyroid tumors.
    Boltze C; Schneider-Stock R; Roessner A; Quednow C; Hoang-Vu C
    Pathol Res Pract; 2003; 199(9):573-9. PubMed ID: 14621192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable association of hsp90 and p23, but Not hsp70, with active human telomerase.
    Forsythe HL; Jarvis JL; Turner JW; Elmore LW; Holt SE
    J Biol Chem; 2001 May; 276(19):15571-4. PubMed ID: 11274138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin inhibits nuclear localization of telomerase by dissociating the Hsp90 co-chaperone p23 from hTERT.
    Lee JH; Chung IK
    Cancer Lett; 2010 Apr; 290(1):76-86. PubMed ID: 19751963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.
    Boltze C; Lehnert H; Schneider-Stock R; Peters B; Hoang-Vu C; Roessner A
    Endocrine; 2003 Dec; 22(3):193-201. PubMed ID: 14709792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biochemical role of the heat shock protein 90 chaperone complex in establishing human telomerase activity.
    Keppler BR; Grady AT; Jarstfer MB
    J Biol Chem; 2006 Jul; 281(29):19840-8. PubMed ID: 16714764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90-binding immunophilin FKBP52 modulates telomerase activity by promoting the cytoplasmic retrotransport of hTERT.
    Jeong YY; Her J; Oh SY; Chung IK
    Biochem J; 2016 Oct; 473(20):3517-3532. PubMed ID: 27503910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular roles for the molecular chaperone, hsp90.
    Eustace BK; Jay DG
    Cell Cycle; 2004 Sep; 3(9):1098-100. PubMed ID: 15326368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The co-chaperone p23 promotes prostate cancer motility and metastasis.
    Cano LQ; Lavery DN; Sin S; Spanjaard E; Brooke GN; Tilman JD; Abroaf A; Gaughan L; Robson CN; Heer R; Mauri F; de Rooij J; Driouch K; Bevan CL
    Mol Oncol; 2015 Jan; 9(1):295-308. PubMed ID: 25241147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression-patterns of the RNA component (hTR)and the catalytic subunit (hTERT) of human telomerase in nonneoplastic prostate tissue, prostatic intraepithelial neoplasia, and prostate cancer.
    Bettendorf O; Heine B; Kneif S; Eltze E; Semjonow A; Herbst H; Stein H; Böcker W; Poremba C
    Prostate; 2003 May; 55(2):99-104. PubMed ID: 12661034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p23, a simple protein with complex activities.
    Felts SJ; Toft DO
    Cell Stress Chaperones; 2003; 8(2):108-13. PubMed ID: 14627195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells.
    Kim RH; Kim R; Chen W; Hu S; Shin KH; Park NH; Kang MK
    Carcinogenesis; 2008 Dec; 29(12):2425-31. PubMed ID: 18820283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional requirement of p23 and Hsp90 in telomerase complexes.
    Holt SE; Aisner DL; Baur J; Tesmer VM; Dy M; Ouellette M; Trager JB; Morin GB; Toft DO; Shay JW; Wright WE; White MA
    Genes Dev; 1999 Apr; 13(7):817-26. PubMed ID: 10197982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model.
    Moses MA; Henry EC; Ricke WA; Gasiewicz TA
    Cancer Prev Res (Phila); 2015 Mar; 8(3):249-57. PubMed ID: 25604133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer.
    Leav I; Plescia J; Goel HL; Li J; Jiang Z; Cohen RJ; Languino LR; Altieri DC
    Am J Pathol; 2010 Jan; 176(1):393-401. PubMed ID: 19948822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chaperone function of Hsp90-associated proteins.
    Bose S; Weikl T; Bügl H; Buchner J
    Science; 1996 Dec; 274(5293):1715-7. PubMed ID: 8939863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All of the protein interactions that link steroid receptor.hsp90.immunophilin heterocomplexes to cytoplasmic dynein are common to plant and animal cells.
    Harrell JM; Kurek I; Breiman A; Radanyi C; Renoir JM; Pratt WB; Galigniana MD
    Biochemistry; 2002 Apr; 41(17):5581-7. PubMed ID: 11969419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein 90 is associated with hyperplasia and neoplastic transformation of canine prostatic epithelial cells.
    Palmieri C; Mancini M; Benazzi C; Della Salda L
    J Comp Pathol; 2014 May; 150(4):393-8. PubMed ID: 24679854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.